Correlation Between Anebulo Pharmaceuticals and CEL SCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and CEL SCI Corp, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and CEL SCI.

Diversification Opportunities for Anebulo Pharmaceuticals and CEL SCI

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Anebulo and CEL is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and CEL SCI go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and CEL SCI

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.03 times more return on investment than CEL SCI. However, Anebulo Pharmaceuticals is 1.03 times more volatile than CEL SCI Corp. It trades about -0.19 of its potential returns per unit of risk. CEL SCI Corp is currently generating about -0.29 per unit of risk. If you would invest  190.00  in Anebulo Pharmaceuticals on August 30, 2024 and sell it today you would lose (47.00) from holding Anebulo Pharmaceuticals or give up 24.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  CEL SCI Corp

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
CEL SCI Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CEL SCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Anebulo Pharmaceuticals and CEL SCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and CEL SCI

The main advantage of trading using opposite Anebulo Pharmaceuticals and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.
The idea behind Anebulo Pharmaceuticals and CEL SCI Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio